Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GCSHP1, or Glycine cleavage system protein H pseudogene 1, is a non-protein-coding DNA sequence derived from the gene encoding glycine cleavage system protein H (GCSH)[11][14]. Pseudogenes like GCSHP1 typically do not encode functional proteins and have historically been considered "genomic fossils" or nonfunctional DNA. Recent research indicates that some pseudogenes may have regulatory effects at the RNA level, but there is no specific evidence that GCSHP1 has a defined role in human biology or disease[6][8][10]. Unlike the functional GCSH, which participates in glycine metabolism and is associated with inherited metabolic diseases, GCSHP1 does not contribute directly to any known enzymatic activity or signaling pathway[1][3][5][12]. No drugs, biomarkers, or safety data are reported for GCSHP1.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glycine cleavage system protein H pseudogene 1 (GCSHP1).